Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://covid19.nih.gov/

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies
Name Principal Investigator Institution Study Date Approved Project ID
Serum IgE and Risk of Pancreatic Cancer Sara Olson Memorial Sloan-Kettering Cancer Center PLCO Jan 27, 2010 2009-0563
Identification of factors associated with development and progression of monoclonal B-cell lymphocytosis (MBL) Ola Landgren Other (Specify) PLCO Jan 27, 2010 2009-0561
A Mendelian randomization study of diabetes mellitus and prostate cancer risk Brandon Pierce University of Chicago PLCO Jan 21, 2010 2009-0094
Modifying Effects of Variant Oxidative Stress Related Genes in Relation to Prostate Cancer Outcomes LaCreis Kidd University of Louisville PLCO Jan 21, 2010 2009-0244
One-carbon metabolism and risk of lung cancer in a multi-cohort consortium Neil Caporaso DCEG PLCO Jan 18, 2010 2010-0043
DNA Methylation Markers and Prostate Cancer Risk Sonja Berndt NCI, DCEG, OEEB PLCO Dec 15, 2009 2009-0564
Serum Creatinine and Prostate Cancer Risk in the PLCO Study Stephanie Weinstein DCEG - NEB PLCO Dec 15, 2009 2009-0555
Serum Sarcosine, Variation in Sarcosine-related Genes and Subsequent Risk of Prostate Cancer Stella Koutros NCI, DCEG, OEEB PLCO Dec 15, 2009 2009-0565
Association of Human Endogenous Retrovirus K (HERV-K) Expression with Prostate Cancer Development and Progression Stefan Ambs - PLCO Dec 15, 2009 2009-0552
Coronary Artery Calcium Detected on Lung Cancer Screening CT and All-Cause Mortality: The National Lung Screening Trial Janet Snell-Bergeon University of Colorado Health Science Center NLST Dec 8, 2009 200912-0013
Telemore length and risk of glioma Preetha Rajaraman NCI, DCEG, REB PLCO Nov 19, 2009 2009-0557
Reconciling Results of PSA Screening Efficacy Using PLCO and ERSPC data: CISNET modeling project Angela Mariotto NCI, DCCPS, DMB PLCO Nov 12, 2009 2009-0182
New statistical approaches for adjusting seasonal variation in vitamin D concentration measurement, with application in the PLCO nested case-control study of serum vitamin D concentration and prostate cancer risk Kai Yu NCI, DCEG, BB PLCO Nov 11, 2009 2009-0006
Trichomonosis and prostate cancer risk in the Prostate, Lung, Colorectal & Ovarian Cancer Screening Trial Siobhan Sutcliffe Washington University PLCO Nov 9, 2009 2009-0556
Investigation of Prostate Cancer Risk Factors and Targeted Screening Amanda Black NCI, DCEG, EBP PLCO Nov 4, 2009 2009-0243
Modifiable risk factors for benign prostatic hyperplasia Siobhan Sutcliffe Washington University PLCO Nov 4, 2009 2009-0167
Development and Validation of a Prediction Model for Identifying Small Malignant Pulmonary Nodules Gerard Silvestri Medical University of South Carolina NLST Oct 19, 2009 200910-0040
Factors influencing prostate cancer mortality David Crawford Univeristy of Colorado Health Science Center PLCO Oct 1, 2009 2009-0012
Reproductive history and renal cell carcinoma Mark Purdue NCI, DCEG, OEEB PLCO Oct 1, 2009 2009-0172
Estimated Radiation Dose to Participants Receiving Chest X-Rays in the National Lung Screening Trial (NLST) Michael Flynn Henry Ford Health System NLST Sep 28, 2009 200909-0088